| Name | Kroger Pharmacy #469 |
|---|---|
| Organization Name | The Kroger Co |
| Location | 11877 Douglas Rd, Alpharetta, Georgia 30005 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (770) 751-3651 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
New research finds that one out of 12 people who have a stroke will likely soon have another stroke, and one out of four will likely die within one year. Researchers say the findings highlight the vital need for better secondary stroke prevention. The study is published in the February 16, 2010, issue of Neurology-, the medical journal of the American Academy of Neurology.
Forest Laboratories, Inc. announced that it received a subpoena from the Office of the U.S. Attorney for the District of Massachusetts dated April 20, 2011.
Dana-Farber/Boston Children's Cancer and Blood Disorders Center has joined a clinical trial of immunotherapy for children with relapsed or treatment-resistant acute lymphoblastic leukemia (ALL). Led by Memorial Sloan Kettering Cancer Center, the trial is one of several nationally that are evaluating cancer immunotherapy, a treatment approach - hailed by Science magazine as their Breakthrough of the Year in 2013 - that triggers a patient's immune system to attack his or her cancer cells.
The second phase of the Integrated Health Care program to control tuberculosis has been implemented in Zimbabwe's capital of Harare, the Herald reports.
› Verified 7 days ago
| NPI Number | 1891729604 |
| Organization Name | THE KROGER CO |
| Doing Business As | KROGER PHARMACY |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 11877 Douglas Rd, Alpharetta, GA 30005 |
| Phone Number | 770-751-3651 |
News Archive
New research finds that one out of 12 people who have a stroke will likely soon have another stroke, and one out of four will likely die within one year. Researchers say the findings highlight the vital need for better secondary stroke prevention. The study is published in the February 16, 2010, issue of Neurology-, the medical journal of the American Academy of Neurology.
Forest Laboratories, Inc. announced that it received a subpoena from the Office of the U.S. Attorney for the District of Massachusetts dated April 20, 2011.
Dana-Farber/Boston Children's Cancer and Blood Disorders Center has joined a clinical trial of immunotherapy for children with relapsed or treatment-resistant acute lymphoblastic leukemia (ALL). Led by Memorial Sloan Kettering Cancer Center, the trial is one of several nationally that are evaluating cancer immunotherapy, a treatment approach - hailed by Science magazine as their Breakthrough of the Year in 2013 - that triggers a patient's immune system to attack his or her cancer cells.
The second phase of the Integrated Health Care program to control tuberculosis has been implemented in Zimbabwe's capital of Harare, the Herald reports.
› Verified 7 days ago
News Archive
New research finds that one out of 12 people who have a stroke will likely soon have another stroke, and one out of four will likely die within one year. Researchers say the findings highlight the vital need for better secondary stroke prevention. The study is published in the February 16, 2010, issue of Neurology-, the medical journal of the American Academy of Neurology.
Forest Laboratories, Inc. announced that it received a subpoena from the Office of the U.S. Attorney for the District of Massachusetts dated April 20, 2011.
Dana-Farber/Boston Children's Cancer and Blood Disorders Center has joined a clinical trial of immunotherapy for children with relapsed or treatment-resistant acute lymphoblastic leukemia (ALL). Led by Memorial Sloan Kettering Cancer Center, the trial is one of several nationally that are evaluating cancer immunotherapy, a treatment approach - hailed by Science magazine as their Breakthrough of the Year in 2013 - that triggers a patient's immune system to attack his or her cancer cells.
The second phase of the Integrated Health Care program to control tuberculosis has been implemented in Zimbabwe's capital of Harare, the Herald reports.
› Verified 7 days ago
Bio-tech Orthotic & Prothetic Servi Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4895 Windward Pkwy, Alpharetta, Georgia 30004 Phone: (404) 600-2072 | |
Cornerstone Medical Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2660 Holcomb Bridge Rd, Alpharetta, Georgia 30022 Phone: (770) 399-7337 | |
Cvs Pharmacy # 02185 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 184 N Main St, Alpharetta, Georgia 30009 Phone: (678) 297-1089 | |
Cvs Pharmacy # 02309 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3020 Windward Plz, Alpharetta, Georgia 30005 Phone: (770) 475-3638 | |
Cvs Pharmacy # 02539 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5740 Atlanta Hwy, Alpharetta, Georgia 30004 Phone: (678) 366-7954 |